Meta-Analysis
Copyright ©The Author(s) 2020.
World J Cardiol. Nov 26, 2020; 12(11): 571-583
Published online Nov 26, 2020. doi: 10.4330/wjc.v12.i11.571
Table 2 Demographic comparison based on secondary access of matched/adjusted data (if available)
Junquera et al[2]
Fernandez-Lopez et al[6]
Jackson et al[5]
Allende et al[4]
Curran et al[3]

TFSA (n = 2978)
TRSA (n = 928)
TFSA (n = 194)
TRSA (n = 217)
TFSA (n = 64)
TRSA (n = 135)
TFSA (n = 335)
TRSA (n = 127)
TFSA (n = 41)
TRSA (n = 46)
Baseline characteristics of patients
Age81 ± 481 ± 883 ± 782 ± 682 ± 682 ± 779 ± 880 ± 980 ± 1080 ± 5
%Male52.60%53.20%44.80%53.50%57.00%43.00%45.00%61.00%31.70%52.20%
Baseline comorbidities
Diabetes26.90%27.00%31.40%24.40%20.00%20.00%35.00%31.00%30.00%26.10%
HTN--56.70%55.30%--88.00%84.00%92.50%80.40%
CAD51.20%50.30%--53.00%52.60%67.00%63.00%--
Previous CABG19.80%19.60%4.10%6.00%20.00%19.30%39.00%33.00%17.10%17.40%
AFib33.50%34.70%27.80%33.60%25.00%25.00%17.00%20.00%--
PVD16.30%19.20%13.40%14.30%18.00%26.70%40.00%24.00%--
Prior CVA--10.30%10.60%17.00%16.30%19.00%16.00%--
eGFR < 60 mL/min/1.73 m267.60%69.40%----57.00%51.00%--
COPD/Pul disease21.30%20.90%11.90%13.40%25.00%25.90%29.00%25.00%20.00%13.00%
STS-PROM score4.54.75.0 ± 3.04.8 ± 3.6--7.1 ± 4.57.2 ± 5.09.0 ± 7.8 7.2 ± 7.5
Valve type
Balloon-expandable60.00%63.50%NANANANA96.00%88.00%NANA
Self-expandable40.00%36.50%NANANANA3.00%10.00%NANA
1° Access
TFPA88.50%89.90%100%100%100%85.20%30.80%93.00%100%100%
Non-TFPA11.50%10.10%00014.80%69.20%7.00%00
Transapical 9.10%3.70%58.20%6.00%
Transaortic 1.90%8.80%10.70%1.00%
Subclavian 1.50%2.20%0.30%0
Transcarotid 4.06%000
Transcaval 0.12%000